Oracle's Tightrope Walk: Quantum Ambitions, Layoff Rumors, and a Balance Sheet Under Scrutiny
Published on 09/02/2026 at 13:02 | Editorial boerse-global.de
Oracle is telling two stories at once, and investors are struggling to decide which one to believe. On one hand, the company is pushing forward with a multi-year partnership with Quantinuum to bring hybrid quantum computing to its cloud infrastructure, targeting applications in drug discovery, materials science, and artificial intelligence. On the other, reports have circulated since Tuesday suggesting that between 7,000 and 10,000 jobs could be cut globally, timed around the start of the company's second fiscal quarter.
The simultaneity of these developments is telling. A company that wants to be seen as a leader in next-generation computing is simultaneously preparing what could be one of the largest workforce reductions in its recent history. Neither story exists in isolation, and the tension between them defines Oracle's current predicament.
Unconfirmed Reports, Palpable Anxiety
The layoff rumors remain unconfirmed. Employees reportedly expected an email at six o'clock Tuesday morning that never arrived — a small detail that speaks volumes about how prepared the workforce already is for a significant restructuring. Media reports suggest that India alone could see up to 3,000 positions eliminated. Oracle has not commented on any of the figures.
This pattern is familiar: internal concerns leak to the outside world before the company makes an official statement. The human cost is real, but so is the strategic question underneath it.
The Numbers Behind the Narrative
The financial picture adds weight to these concerns. Oracle's recent results, covering the past fiscal year, show revenue up 17 percent to $67.4 billion, with cloud infrastructure revenue surging 77 percent to $18.1 billion. The company's backlog stands at $638 billion — a figure management has touted repeatedly.
Should investors sell immediately? Or is it worth buying Oracle?
Yet the balance sheet tells a different story. Free cash flow came in at negative $23.7 billion. The company has taken on an additional $43 billion in debt, with another $40 billion reportedly planned. Leasing commitments add roughly $260 billion to the obligations. Capital expenditures jumped from $21.2 billion in the prior year to $55.7 billion.
CEO Mike Sicilia, speaking at a Deutsche Bank conference, framed the workforce reductions as a productivity leap driven by AI-assisted development, claiming engineers are reaching "science-fiction levels" of output. He offered no concrete metrics to back that assertion. Skeptics see it differently: a company with exploding investment demands needs to find savings somewhere, and headcount is the most immediate lever available.
This is not unique to Oracle. Meta, Amazon, and Microsoft are all trimming staff while pouring billions into AI data centers. But Oracle's reliance on debt financing makes the balancing act more precarious than it is for better-capitalized rivals.
Wall Street Takes Notice
TD Cowen has responded by cutting its price target on Oracle from $300 to $240, while maintaining a buy rating. That combination is notable: the analysts still believe in the long-term potential but no longer trust the current valuation level. The broader consensus price target remains well above where the stock trades, suggesting skepticism has not yet become universal — but it is spreading.
The market has already absorbed much of the bad news. The stock closed at €121.74 yesterday, down 5.1 percent, with a seven-day decline of 4.7 percent and a year-to-date loss of 27 percent. In another recent session, the shares were quoted at €120.32, roughly 59 percent below the 52-week high of €294.85 reached last September. The stock sits within 19 percent of its 52-week low of €100.76, set this summer — evidence that investors have already priced in substantial risk.
Technically, the shares are trading almost exactly at their 50-day moving average of €121.60, but remain about 17 percent below the 200-day average of €145.90. The RSI stands at 46, indicating neither oversold nor overbought conditions. The stock appears to be searching for a floor rather than establishing one.
Regulatory Clouds Gather
The financial strain is not Oracle's only headache. The European Commission is examining the company's licensing practices, gathering information from third parties. This is not yet a formal investigation, but a precedent exists: SAP reached a settlement in July involving concessions to avoid a fine of up to 10 percent of global revenue in a similar case. Should Brussels pursue Oracle along the same lines, the timing could hardly be worse.
Oracle at a turning point? This analysis reveals what investors need to know now.
There is also a legal chapter winding down on the other side of the Atlantic. A $115 million settlement payment in a privacy case is scheduled to be distributed starting September 21, according to Reuters, following the conclusion of all appeal proceedings in June. The sum is modest compared to the scale of the potential layoffs, but it serves as a reminder that Oracle is navigating legal, personnel, and strategic challenges simultaneously.
A Company Caught Between Promises and Payments
Oracle's fiscal 2027 targets remain ambitious: $90 billion in revenue and earnings of $8.05 per share, reaffirmed in August alongside fourth-quarter results. Those figures now stand in tension with reports of mass layoffs and a balance sheet under visible strain.
The company's workforce has already shrunk from roughly 162,000 employees in May 2025 to 141,000 in May 2026 — a decline of about 13 percent in a single year. The additional reported cuts in India follow 12,000 job eliminations there in March.
The central question is whether Oracle can reconcile its growth narrative with its financial reality. The backlog of $638 billion is a promise, not a guarantee. The company is reaching forward into quantum computing with one hand while tightening its belt with the other. Whether these two movements add up to a coherent strategy will become clearer on September 10, when Oracle reports first-quarter results for fiscal 2027 — and investors will be looking for numbers, not rumors, to settle the debate.
Ad
Oracle Stock: New Analysis - 2 September
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
